Home › Compare › NVRVF vs ABBV
NVRVF yields 2000.00% · ABBV yields 3.06%● Live data
📍 NVRVF pulled ahead of the other in Year 1
Combined, NVRVF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NVRVF + ABBV for your $10,000?
Novra Technologies Inc., together with its subsidiaries, provides hardware, software, and services for the distribution of satellite data in Canada, North America, Central America, South America, Europe, the Middle East, Africa, East Asia, South Asia, Southeast Asia, and Oceania. The company offers video distribution products and systems for the provision of end-to-end solutions to traditional and non-traditional video networks; infrastructure solutions for broadcast radio networks, including uplink and receive site equipment, as well as network management, encryption, and targeted regionalization/ad insertion options; and data distribution for hardware infrastructure, as well as content distribution network software solution. It also provides digital cinema network infrastructure and services; appliances for cinemas; decoders for live events; alternative content in 2D and 3D; digital cinema distribution software solutions; and DVB and ATSC compliant receivers for the broadband communications network market. The company was founded in 2000 and is headquartered in Winnipeg, Canada.
Full NVRVF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.